Laparoscopy-Assisted Radical Nephrectomy with Inferior Vena Caval Thrombectomy for Level II to III Tumor Thrombus: A Single-Institution Experience and Review of the Literature

2010 ◽  
Vol 24 (6) ◽  
pp. 1005-1012 ◽  
Author(s):  
An N. Hoang ◽  
Ara A. Vaporcyian ◽  
Surena F. Matin
Keyword(s):  
Radical Nephrectomy ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Review Of The Literature ◽  
Single Institution ◽  
Inferior Vena Caval ◽  
Level Ii

scholarly journals Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level II-III venous tumor thrombus

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhuo Liu ◽  
Peng Hong ◽  
Guodong Zhu ◽  
Li Zhang ◽  
Xun Zhao ◽  
...  
Keyword(s):  
Laparoscopic Surgery ◽  
Inferior Vena Cava ◽  
Radical Nephrectomy ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Renal Tumor ◽  
Vena Cava ◽  
Level Ii ◽  
Venous Tumor Thrombus ◽  
The Mean

Abstract Purpose To explore the safety and effectiveness of delayed occlusion of the proximal inferior vena cava (DOPI) technique in retroperitoneal laparoscopic radical nephrectomy (LRN) and thrombectomy for renal tumor with level II-III venous tumor thrombus (VTT). Materials and methods From August 2016 to October 2018, a total of 145 patients with renal tumor and VTT were admitted to our centre. Seventy-five patients underwent laparoscopic surgery, and 70 patients underwent open surgery. Among these patients, 17 patients underwent retroperitoneal LRN and thrombectomy with the DOPI technique. Clinical data were collected retrospectively, and a descriptive statistical analysis was conducted. Results All the patients successfully underwent retroperitoneal laparoscopic surgery. The mean operation time was 345.9 ± 182.9 min, the mean estimated blood loss was 466.7 ± 245.5 ml. Postoperative complications occurred in three patients, including two patients of Clavien grading system level IVa and one patient of level II. There were no complications related to carbon dioxide pneumoperitoneum, such as gas embolism, acidosis, and subcutaneous emphysema. During 21 months of median follow-up time, no local recurrence was found, and distant metastasis occurred in four patients. Cancer-specific death occurred in two patients. Conclusions The DOPI technique is safe and feasible in the treatment of renal tumor and level II-III VTT. With the DOPI technique, the procedures of dissociating and exposing proximal inferior vena cava are simplified.

Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level II-III venous tumor thrombus

2021 ◽  
Author(s):  
Zhuo Liu ◽  
Peng Hong ◽  
Guodong Zhu ◽  
Li Zhang ◽  
Xun Zhao ◽  
...  
Keyword(s):  
Laparoscopic Surgery ◽  
Inferior Vena Cava ◽  
Radical Nephrectomy ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Renal Tumor ◽  
Vena Cava ◽  
Level Ii ◽  
Venous Tumor Thrombus ◽  
The Mean

Abstract Purpose To explore the safety and effectiveness of delayed occlusion of the proximal inferior vena cava (DOPI) technique in retroperitoneal laparoscopic radical nephrectomy (LRN) and thrombectomy for renal tumor with level II-III venous tumor thrombus (VTT). Materials and Methods From August 2016 to October 2018, a total of 145 patients with renal tumor and VTT were admitted to our centre. Seventy-five patients underwent laparoscopic surgery, and 70 patients underwent open surgery. Among these patients, 17 patients underwent retroperitoneal LRN and thrombectomy with the DOPI technique. Clinical data were collected retrospectively, and a descriptive statistical analysis was conducted. Results All the patients successfully underwent retroperitoneal laparoscopic surgery. The mean operation time was 345.9 ± 182.9 min; the mean estimated blood loss was 466.7 ± 245.5 ml. Postoperative complications occurred in three patients, including two patients of Clavien grading system level IVa and one patient of level II. There were no complications related to carbon dioxide pneumoperitoneum, such as gas embolism, acidosis, and subcutaneous emphysema. During 21 months of median follow-up time, no local recurrence was found, and distant metastasis occurred in four patients. Cancer-specific death occurred in two patients. Conclusions The DOPI technique is safe and feasible in the treatment of renal tumor and level II-III VTT. With the DOPI technique, the procedures of dissociating and exposing proximal inferior vena cava are simplified.

Computerized Tomographic Demonstration of Inferior Vena Caval Tumor Thrombus from Renal Angiomyolipoma

1985 ◽  
Vol 133 (5) ◽  
pp. 836-837 ◽  
Author(s):  
Robert E. Brantley ◽  
Joseph W. Mashni ◽  
Rolland E. Bethards ◽  
Ann E. Chernys ◽  
Woon Man Chung
Keyword(s):  
Tumor Thrombus ◽  
Inferior Vena ◽  
Renal Angiomyolipoma ◽  
Inferior Vena Caval ◽  
Caval Tumor Thrombus

Inferior vena caval tumor thrombus extending into the right atrium in a patient with pancreatic cancer

2007 ◽  
Vol 24 (3) ◽  
pp. 317-321 ◽  
Author(s):  
Beste Ozben ◽  
Nurdan Papila ◽  
M. Azra Tanrikulu ◽  
Fatih Bayalan ◽  
Ali Serdar Fak ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Right Atrium ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Inferior Vena Caval ◽  
The Right ◽  
Caval Tumor Thrombus

Prognostic value of BAP1 expression in clear cell renal cell carcinoma with inferior vena cava tumor thrombosis.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e16080-e16080
Author(s):  
Suguru Oka ◽  
Naoko Inoshita ◽  
Yuji Miura ◽  
Ryosuke Oki ◽  
Yu Miyama ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Renal Cell ◽  
Radical Nephrectomy ◽  
Poor Prognosis ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Clear Cell ◽  
Vena Cava ◽  
Ivc Tumor

e16080 Background: Renal cell carcinoma (RCC) is characterized by a propensity for extension into the renal vein and inferior vena cava (IVC), and affected patients have a poor prognosis. BAP1 mutation, which occurs in about 15% of patients with clear cell RCC (ccRCC), also predicts a poor prognosis. The aim of this study was to elucidate the association between BAP1 expression and clinicopathologic outcomes in patients with ccRCC with an IVC tumor thrombus. Methods: Thirty-nine patients with ccRCC with an IVC tumor thrombus who underwent radical nephrectomy and tumor thrombectomy at our institution from 1999 to 2010 were retrospectively evaluated. Immunohistochemical analyses were performed for the expression of BAP1, and the associations between the expression of BAP1 and clinical outcomes were assessed. Survival analyses were performed using the Kaplan–Meier method and log-rank test. Multivariate analyses of the associations between overall survival (OS) and clinical variables were performed using a Cox proportional hazard model. For all analyses, P < 0.05 was considered statistically significant. Results: The median follow-up time was 58.8 months (range, 2–130 months). The median age was 66 years (range, 37–80 years). Four patients (10.3%) had lung metastasis at the initial diagnosis. The primary tumor was right-sided in 27 (69.2%) patients and left-sided in 12 (30.8%). The IVC tumor thrombus extended above and below the diaphragm in 11 (28.2%) and 28 (71.8%) patients, respectively. The KPS score was > 80 in 23 patients (59.0%). BAP1 expression was positive in 26 (67.0%) cases and negative in 13 (33.0%). BAP1-negative tumors were associated with a significantly shorter OS than BAP1-positive tumors (median OS, 42.0 vs. 81.5 months, respectively; P = 0.019). The median disease-free survival in BAP1-negative and -positive tumors was 10.0 and 19.0 months, respectively (P = 0.019). Multivariate analysis showed that only a BAP1-negative status was significantly associated with shorter OS (P = 0.026). Conclusions: A BAP1-negative tumor status was significantly associated with a poor prognosis in patients with ccRCC with an IVC tumor thrombus who underwent radical nephrectomy and tumor thrombectomy.

Sign in / Sign up

Export Citation Format

Share Document